Pharmafile Logo
Pharmafocus logo
Advanced Search
opioid_naloxone_device

Researchers design automatic opioid overdose antidote device

July 25, 2019
Research and Development naloxone, opioid crisis, opioids, pharma, purdue university

Researchers at Purdue University are developing a device that would automatically detect an overdose in opioid users and release a …

News
lilly_entrance_web

Lilly’s Baqsimi nasal powder gains FDA approval after proving non-inferior to injection

July 25, 2019
Sales and Marketing Baqsimi, Eli Lilly, FDA, US, diabetes, pharma

Eli Lilly has been awarded approval from the FDA for its Baqsimi nasal powder in the treatment of severe hypoglycaemia, …

News

Elizabeth Warren calls on Albert Bourla to reveal detail of appointment of former FDA commissioner Scott Gottlieb to Pfizer’s board

July 25, 2019
Business Services, Medical Communications Albert Bourla, Elizabeth Warren, FDA, Pfizer, Scott Gottlieb, pharma

Elizabeth Warren has called on Pfizer to reveal the details of Scott Gottlieb’s appointment to the company’s Board of Directors.

News
jonathan_symonds

GSK hire Jonathan Symonds as new Chairman

July 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman. The hire ends GSK’s six …

Appointment
mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

July 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by …

Appointment
humira_abbott__4

Humira biosimilar from Samsung Bioepis and MSD wins marketing authorisation in the US

July 24, 2019
Research and Development, Sales and Marketing AbbVie, Humira, MSD, Samsung Bioepis, biosimilars, pharma

It’s another victory for MSD as the US drugmaker announced that its biosimilar version of AbbVie’s Humira – the world’s …

News

Senate puts forward bipartisan bill to lower price of drugs

July 24, 2019
Research and Development PBMs, Senate, USA, access, bipartisan, pharma, pricing

The Senate Finance Committee has introduced a bipartisan bill that aimed at lowering the prices Medicare pays for pharmaceutical drugs. …

News
fda2outsideweb

FDA approves Pfizer’s biosimilar version of Genentech’s Rituxan

July 24, 2019
Research and Development FDA, Pfizer, Rituxan, Ruxience, biosimilars, pharma

Pfizer has seen Ruxience, its biosimilar version of Genentech’s Rituxan (rituximab), approved by the FDA in the treatment of non-Hodgkin …

News

Researchers use machine learning to re-identify ‘anonymous data’

July 24, 2019
Research and Development Big Data, anonymous data, data, patient data, privacy, research

Anonymised data can be traced back to individuals, according to research published in the journal Nature Communications. Anonymised data can …

News
1920px-hiv-budding-color

MSD trials long lasting PrEP implant for preventing HIV

July 23, 2019
Research and Development AIDS, HIV, MSD, PrEP, pharma

MSD is trialling an implant that prevents patients from contracting HIV, The Guardian has said. The US firm has tested …

News
dr_alvin_shih

Disarm Therapeutics hires Dr Alvin Shih as new President and CEO

July 23, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Massachusetts-based biotech Disarm Therapeutics has hired Dr Alvin Shih as their new President and CEO. The Cambridge, Mass.-based firm has …

Appointment
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous formulation of Entyvio smashes primary endpoint in Crohn’s disease

July 23, 2019
Manufacturing and Production, Research and Development Crohn’s disease, Entyvio, Takeda, crohn's disease, pharma

Takeda has unveiled new Phase 3 data for a subcutaneous formulation of its gut-selective biologic Entyvio (vedolizumab), showing that the …

News
bug_plants_insect_leaf_nature_macrophotography_naturephotography_macro-1046343

Drug resistant malaria spreads in South East Asia

July 23, 2019
Manufacturing and Production South East Asia, global health, infectious diseases, malaria, parasites

Drug resistant malaria parasites are spreading rapidly in South East Asia, according to researchers from Thailand and the United Kingdom. …

News

FDA approves nine generic versions of Pfizer’s Lyrica

July 23, 2019
Manufacturing and Production, Sales and Marketing FDA, Lyrica, Pfizer, pharma

The FDA has given its approval to the first generic versions of Pfizer’s Lyrica (pregabalin), it has emerged, giving the …

News
schizophrenia

Acadia’s schizophrenia drug flops in Phase 3 trial

July 23, 2019
Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia

Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …

News
gilead-sciences

Gilead buys Novartis’ herpes, flu and cold virus preclinical programmes

July 23, 2019
Manufacturing and Production Gilead, Novartis, antivrial, deal, herpes, influenza, rhinovirus

Gilead has acquired the rights to three of Novartis’ preclinical antiviral programmes, including investigational compounds with the potential to treat …

News
biohaven_enrolls_first_patient_in-97b6e9e792e571e7c1572873932fc7c0

FDA knocks back Biohaven’s ALS drug over manufacturing concerns

July 22, 2019
Sales and Marketing Biohaven, FDA, Nurtec, amyotrophic lateral sclerosis, pharma

Biohaven Pharmaceutical has seen its new therapy formulation for the treatment of amyotrophic lateral sclerosis (ALS) rejected by the FDA, …

News
nice_new_london_office_internal_2_8

NICE to review its decision making processes

July 22, 2019
Sales and Marketing Cost, NHS, NICE, UK, britain, pharma

Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, …

News
celgene_building

Celgene’s Otezla becomes first and only FDA-approved therapy for oral ulcers in Behçet’s Disease

July 22, 2019
Sales and Marketing Behçet's disease, Behçet’s Disease, Celgene, apremilast, otezla, pharma

Celgene has revealed the US approval of Otezla (apremilast), confirming that the FDA awarded marketing authorisation for the treatment of …

News
bottle_of_lies_3d_bookshot_w_logo_

Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world

July 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Contamination, FDA, India, chin, compliance, manufacturing, pharma, regulation, valsartan

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the quality of generics has been …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026